"Пациенты с легкостью доверяют заботу о своем здоровье клинике «Эс Класс Клиник» в Ульяновске, которая предлагает выгодные условия по диагностике и лечению различных заболеваний, ежедневно принимает посетителей в любое удобное время. В медицинском центре занимаются омоложением, лечением женских и мужских заболеваний, применяют вспомогательные репродуктивные технологии, помогают семейным парам завести детей. Особо востребованными процедурами здесь являются УЗИ, общеклинические, цитологические, гистологические, биохимические, гормональные исследования. В заведении установлены доступные расценки на все виды услуг. Коллектив центра уважает частную жизнь посетителей, гарантирует каждому обратившемуся полную конфиденциальность."

During the past decade, SHI Ulyanovsk Reg Clinical Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SHI Ulyanovsk Reg Clinical Hospital" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "SHI Ulyanovsk Reg Clinical Hospital" are "Rheumatoid Arthritis" (3 trials), "Dyslipidemia" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "SHI Ulyanovsk Reg Clinical Hospital" in a lesser frequency.

Most popular intervention types in "SHI Ulyanovsk Reg Clinical Hospital" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "GDC-0853" (2 trials), "Placebo" (2 trials), "Adalimumab" (1 trials), "Adalimumab - GP2017" (1 trials) and "Adalimumab - US licensed Humira" (1 trials). Other intervention names were less common.

The vast majority of trials in "SHI Ulyanovsk Reg Clinical Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "SHI Ulyanovsk Reg Clinical Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SHI Ulyanovsk Reg Clinical Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SHI Ulyanovsk Reg Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".